These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27760513)

  • 1. Normal activities of AMP-deaminase and adenylate kinase in patients with McArdle disease.
    Joshi PR; Apitz T; Zierz S
    Neurol Res; 2016 Dec; 38(12):1052-1055. PubMed ID: 27760513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzymes of adenylate metabolism and their role in hibernation of the white-tailed prairie dog, Cynomys leucurus.
    English TE; Storey KB
    Arch Biochem Biophys; 2000 Apr; 376(1):91-100. PubMed ID: 10729194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of 5'-adenosine monophosphate deaminase in the freeze tolerant wood frog, Rana sylvatica.
    Dieni CA; Storey KB
    BMC Biochem; 2008 Apr; 9():12. PubMed ID: 18430211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [AMP-deaminase: regulation and physiological role of the enzyme].
    Lushak VI
    Ukr Biokhim Zh (1999); 2000; 72(1):9-20. PubMed ID: 10979554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactate and Energy Metabolism During Exercise in Patients With Blocked Glycogenolysis (McArdle Disease).
    Ørngreen MC; Jeppesen TD; Taivassalo T; Hauerslev S; Preisler N; Heinicke K; Haller RG; Vissing J; van Hall G
    J Clin Endocrinol Metab; 2015 Aug; 100(8):E1096-104. PubMed ID: 26030324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splice mutations preserve myophosphorylase activity that ameliorates the phenotype in McArdle disease.
    Vissing J; Duno M; Schwartz M; Haller RG
    Brain; 2009 Jun; 132(Pt 6):1545-52. PubMed ID: 19433441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of AMP deaminase as therapeutic target in cardiovascular pathology.
    Zabielska MA; Borkowski T; Slominska EM; Smolenski RT
    Pharmacol Rep; 2015 Aug; 67(4):682-8. PubMed ID: 26321268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of AMP-regulated protein kinase and AMP-deaminase in the heart of mice fed high-fat diet.
    Rybakowska I; Slominska EM; Romaszko P; Lipiński M; Zukowska P; Smolenski RT
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):347-52. PubMed ID: 24940692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise testing-based algorithms to diagnose McArdle disease and MAD defects.
    Noury JB; Zagnoli F; Carré JL; Drouillard I; Petit F; Le Maréchal C; Marcorelles P; Rannou F
    Acta Neurol Scand; 2018 Oct; 138(4):301-307. PubMed ID: 29749052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise causes branched-chain oxoacid dehydrogenase dephosphorylation but not AMP deaminase binding.
    Rush JW; MacLean DA; Hultman E; Graham TE
    J Appl Physiol (1985); 1995 Jun; 78(6):2193-200. PubMed ID: 7665417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is muscle glycogenolysis impaired in X-linked phosphorylase b kinase deficiency?
    Ørngreen MC; Schelhaas HJ; Jeppesen TD; Akman HO; Wevers RA; Andersen ST; ter Laak HJ; van Diggelen OP; DiMauro S; Vissing J
    Neurology; 2008 May; 70(20):1876-82. PubMed ID: 18401027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMP-deaminase from thymus of patients with myasthenia gravis.
    Rybakowska I; Szydłowska M; Szrok S; Bakuła S; Kaletha K
    Nucleosides Nucleotides Nucleic Acids; 2015; 34(3):229-34. PubMed ID: 25710358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of adenylate kinase, AMP deaminase and 5'-nucleotidase in the metabolism of adenylic nucleotides].
    Litovchenko IN; Savitskiĭ IV
    Biokhimiia; 1984 Aug; 49(8):1248-52. PubMed ID: 6093896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative enzymology of AMP deaminase, adenylate kinase, and creatine kinase in vertebrate heart and skeletal muscle: the characteristic AMP deaminase levels of skeletal versus cardiac muscle are reversed in the North American toad.
    Fishbein WN; Davis JI; Foellmer JW
    J Comp Physiol B; 1993; 163(3):175-81. PubMed ID: 8394393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and physiological investigations on adenosine 5' monophosphate deaminase from Plasmodium spp.
    Nagappa LK; Singh D; Dey S; Kumar KA; Balaram H
    Mol Microbiol; 2019 Aug; 112(2):699-717. PubMed ID: 31132185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical analysis of human skeletal muscle AMP deaminase deficiency. Evidence of a correlation between the muscle HPRG content and the level of the residual AMP deaminase activity.
    Sabbatini AR; Toscano A; Aguennouz M; Martini D; Polizzi E; Ranieri-Raggi M; Moir AJ; Migliorato A; Musumeci O; Vita G; Raggi A
    J Muscle Res Cell Motil; 2006; 27(1):83-92. PubMed ID: 16570231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and kinetic alterations of muscle AMP deaminase during chronic creatine depletion.
    Rush JW; Tullson PC; Terjung RL
    Am J Physiol; 1998 Feb; 274(2):C465-71. PubMed ID: 9486137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMPD1 genotypes and exercise capacity in McArdle patients.
    Rubio JC; Pérez M; Maté-Muñoz JL; García-Consuegra I; Chamorro-Viña C; Fernández del Valle M; Andreu AL; Martín MA; Arenas J; Lucia A
    Int J Sports Med; 2008 Apr; 29(4):331-5. PubMed ID: 17687759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMP deaminase deficiency is associated with lower sprint cycling performance in healthy subjects.
    Fischer H; Esbjörnsson M; Sabina RL; Strömberg A; Peyrard-Janvid M; Norman B
    J Appl Physiol (1985); 2007 Jul; 103(1):315-22. PubMed ID: 17463303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overproduction, Purification and Characterization of Adenylate Deaminase from Aspergillus oryzae.
    Li S; Qian Y; Liang Y; Chen X; Zhao M; Guo Y; Pang Z
    Appl Biochem Biotechnol; 2016 Dec; 180(8):1635-1643. PubMed ID: 27539573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.